Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Num Vapocoolant Spray is a sterile topical anesthetic spray (vapocoolant/skin refrigerant) designed for rapid, temporary pain relief during minor surgical procedures (such as lancing boils and drainage of small abscesses), injections (venipuncture, IV starts), and the temporary relief of minor sports injuries. It works by rapidly cooling the skin through evaporation of its volatile components—primarily 1,1,1,3,3-pentafluoropropane (95%) and 1,1,1,2-tetrafluoroethane (5%)—which impedes nociceptor stimulation and thus reduces the perception of pain. The product is single-use and radiation sterilized to minimize contamination risk. It acts instantly upon application with effects lasting about one minute[2][5][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Num Vapocoolant Spray.